Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | TDP2 | O95551 | 1/20 | 0.35 |
| ▸ | NSD2 | O96028 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11464954 | 0.87 | ACHE (0.33) | TSHRACHE | |
| SCHEMBL37955 | 0.79 | TSHR (0.45) | CYP1A2TSHRCYP2A6TDP2NSD2 | |
| SCHEMBL5494672 | 0.79 | TSHR (0.45) | CYP1A2TSHRCYP2A6TDP2NSD2 | |
| SCHEMBL7612449 | 0.79 | CYP1A2 (0.33) | CYP1A2TSHRCYP2A6TDP2NSD2 | |
| SCHEMBL10592780 | 0.79 | POLB (0.31) | CYP1A2POLB | |
| SCHEMBL571577 | 0.75 | TSHR (0.43) | CYP1A2TSHRCYP2A6TDP2NSD2 | |
| SCHEMBL10346182 | 0.75 | TSHR (0.43) | CYP1A2TSHRCYP2A6TDP2NSD2 | |
| SCHEMBL5181689 | 0.75 | TSHR (0.43) | CYP1A2TSHRCYP2A6TDP2NSD2 | |
| SCHEMBL5958211 | 0.75 | TRPA1 (0.39) | CYP1A2TSHRCYP2A6TDP2NSD2 | |
| SCHEMBL231107 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1486 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240026432-A1 | POLYVINYL SULFONATE DETECTION AND REMOVAL FROM BIOMOLECULE COMPOSITIONS | AMGEN INC. | 2024-01-25 | — | — | US | claimed |
| EP-4229219-A2 | POLYVINYL SULFONATE DETECTION AND REMOVAL FROM BIOMOLECULE COMPOSITIONS | Amgen Inc. (US) | 2023-08-23 | — | — | EP | claimed |
| CN-116368239-A | Detection and removal of polyvinylsulfonates from biomolecular compositions | 美国安进公司 | 2023-06-30 | — | — | CN | claimed |
| WO-2022081939-A2 | POLYVINYL SULFONATE DETECTION AND REMOVAL FROM BIOMOLECULE COMPOSITIONS | AMGEN INC. (US) | 2022-04-21 | — | — | WO | claimed |
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | SKC CO., LTD. (KR) | 2022-02-15 | — | — | US | claimed |
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SK PUCORE CO., LTD. (KR) | 2019-08-29 | — | — | US | claimed |
| EP-3530684-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SKC Co., Ltd. (KR) | 2019-08-28 | — | — | EP | claimed |
| US-20160304459-A1 | NOVEL COMPOUND, PRODUCTION METHOD THEREFOR, AND APPLICATION THEREFOR | TOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES (JP) | 2016-10-20 | — | — | US | claimed |
| EP-2757180-A1 | A process for electrolytically depositing a tin- and ruthenium-based alloy, the electrolytic bath that permits said alloy to deposit and the alloy obtained by means of said process | Valmet S.p.A. (IT) | 2014-07-23 | — | — | EP | claimed |
| US-8299072-B2 | Pyrazolylmethylamine compounds as calcium channel modulators and preparation method thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2012-10-30 | — | — | US | claimed |
| US-5359017-A | Using an organoiron compound | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1994-10-25 | — | — | US | claimed |
| WO-1994022911-A2 | A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING Nα-METHYLARGININE | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-10-13 | — | — | WO | claimed |
| US-5192767-A | Nonphytotoxic | BASF AKTIENGESELLSCHAFT (DE) | 1993-03-09 | — | — | US | claimed |
| EP-0511405-A1 | CATIONICALLY POLYMERIZABLE ORGANIC MATERIAL COMPOSITION AND STABILIZATION OF SAID COMPOSITION | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1992-11-04 | — | — | EP | claimed |
| EP-0422843-A2 | 6-0 Methylerythromycin A oxime derivatives | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1991-04-17 | — | — | EP | claimed |
| US-4976889-A | 4-formylaminopiperidine derivatives, their use as stabilizers and organic material stabilized with the said derivatives | BASF AKTIENGESELLSCHAFT (DE) | 1990-12-11 | — | — | US | claimed |
| US-4931509-A | EPOXY-CONTAINING MONOMER; EXCELLENT VULCANIZING WITH UREAS, QUATERNARY AMMONIUM AND PHOSPHONIUM SALTS AND POLYCARBOXYLIC ACIDS OR ANHYDRIDES | NIPPON ZEON CO., LTD. (JP) | 1990-06-05 | — | — | US | claimed |
| US-4792644-A | ZEOLITE AND QUATERNARY AMMONIUM SALT | TOSOH CORPORATION (JP) | 1988-12-20 | — | — | US | claimed |
| EP-0073566-A1 | Methods and compositions for combating soil pests | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-03-09 | — | — | EP | claimed |
| US-4162278-A | Flame retardant polyphenylene ether resin compositions containing a pentaerythrityl phosphonate | AMERICAN CYANAMID COMPANY (US) | 1979-07-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | PMM2, PGM2, IPMK | CYP1A2 3612/4885TSHR 4018/4885CYP2A6 2896/4885 |
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | PMM2, PGM2, IPMK | CYP1A2 3612/4885TSHR 4018/4885CYP2A6 2896/4885 |
| US-20160304459-A1 | NOVEL COMPOUND, PRODUCTION METHOD THEREFOR, AND APPLICATION THEREFOR | VIP, MRPL21, THEM6 | CYP1A2 4709/4885TSHR 3996/4885CYP2A6 4157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.